帕金森病患者血液细胞中DNA甲基转移酶1水平降低
A O Lavrinova1, E M Litusova1, P A Gagarina1
1Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Center «Kurchatov Institute», mkr. Orlova roshcha, 1, Gatchina, 188300, Russia.
Neuroscience
|October 16, 2025
概括
帕金森病 (PD) 与减少的DNA甲基转移酶1 (DNMT1) 蛋白水平和血液细胞中的全球DNA低甲基化有关. 在PD患者中也观察到高水平的α-synuclein,这表明表观遗传变化在疾病发病过程中的作用.
科学领域:
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 帕金森病 (PD) 的发病包括遗传,表观遗传和环境因素.
- 由DNA甲基转移酶 (DNMTs) 调节的DNA甲基化是一种关键的表观遗传机制.
- 寡合性α-synuclein是PD中的神经毒素,可能通过隔离DNMT1.1来破坏DNA甲基化.
研究的目的:
- 为了评估DNMT1表达,α-synuclein水平,以及L-DOPA-naïve散发性帕金森病 (sPD) 患者的外周血液细胞中的全球DNA甲基化.
- 评估外源多巴胺对DNMT1水平和DNA甲基化在培养的外周血液单核细胞 (PBMCs) 的影响.
主要方法:
- 在CD45+血细胞中分析DNMT1 (mRNA,蛋白质) 和α-synuclein水平.
- 测量总周围血液细胞 (TPBC) 中的全球DNA甲基化和PBMC中的SNCA内突1的测量.
- 在培养的PBMC中评估多巴胺对DNMT1和DNA甲基化的影响.
主要成果:
- 在sPD患者的CD45+血细胞和PBMC分片 (核和细胞质) 中发现了降低的DNMT1蛋白水平.
- 在sPD患者的PBMC中观察到全球DNA低甲基化和SNCA内突1低甲基化.
- 在sPD患者的CD45+血细胞中检测到高水平的α-synuclein.
- 外源性多巴胺没有影响DNMT1水平或培养淋巴细胞中的DNA甲基化.
结论:
- 周围血液细胞中DNMT1蛋白水平降低可能导致帕金森病的发病.
- 全球DNA低甲基化和SNCA内突1低甲基化与零星的帕金森病有关.
- 血液细胞中的α-synuclein升高与PD有关,可能会影响表观遗传修饰.
相关概念视频
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K


